2018-19 Executive Committee members

RePORT consortia have their own leadership structures, committees, and scientific priorities. Two to three representatives from established consortia comprise a RePORT International Executive Committee (EC), which meets by phone regularly to review progress, obstacles, or problems that have emerged and contribute to plans for the annual meeting.  Each is responsible for communicating with their consortium membership. The EC, in conjunction with the U.S. National Institutes of Health (NIH) and host country sponsors, sets the research and scientific priorities.


The RePORT International Coordinating Center (RICC) has been established at FHI 360, in Durham, North Carolina, U.S., and is led by Carol Dukes Hamilton, MD, MHS.  The RICC coordinates RePORT International activities, including facilitating the EC calls, performing regular reviews of data quality and completeness, updating and distributing standard operating procedures and manuals of operation, and providing tools necessary to encourage cross-consortia harmonization. The RICC also serves as the hub for data- and specimen-sharing requests and material transfer agreements and will facilitate collaborative science, including convening an annual scientific meeting.


The RICC is funded by the Division of AIDS, (DAIDS), National Institute for Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), and serves all the consortia.  The individual RePORT consortia are jointly funded by the NIH and their local governments in a bilateral manner.


Sponsors of RePORT Consortia

RePORT India:  The Indian Department of Biotechnology (DBT), the Ministry of Science and Technology, and the Indian Council of Medical Research (ICMR), with co-funding by NIH, DAIDS/NIAID, and OAR.

RePORT Brazil: The Ministry of Health and Department of Science and Technology (Departamento de Ciencia e Tecnologia/Ministério da Saude [DECIT]), with co-funding by OAR and DAIDS/NIAID.

RePORT South Africa: South African Medical Research Council (SAMRC), with support from the South African Department of Science and Technology (DST) and Department of Health (DOH), and NIAID.

RePORT Indonesia: National Institute of Health Research and Development (NIHRD), Ministry of Health (Indonesia), and Division of Clinical Research (DCR), NIAID.

RePORT China: China Innovation Alliance on Tuberculosis Diagnosis and Treatment (Beijing), and China Ministry of Science and Technology, with co-funding from six China Clinical Trials Consortuim (CTCTC) member centers cooperating with RICC.